| Sep 11 |
Why Relay Therapeutics Plummeted by Nearly 14% Today
|
| Sep 11 |
Relay Therapeutics' RLY-2608 Shows Promise For Breast Cancer With PI3Kα Mutations
|
| Sep 11 |
Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
|
| Sep 11 |
Relay Therapeutics prices $200M stock offering
|
| Sep 11 |
Relay Therapeutics Announces Pricing of Public Offering of Common Stock
|
| Sep 10 |
Relay upgraded by Jefferies, downgraded by Oppenheimer
|
| Sep 10 |
Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market
|
| Sep 10 |
Relay Stock Soars on Upbeat Data From Breast Cancer Study
|
| Sep 9 |
Relay Therapeutics announces proposed public offering of common stock
|
| Sep 9 |
Relay Therapeutics Announces Proposed Public Offering of Common Stock
|
